GLP2-2G-XTEN: A Pharmaceutical Protein With Improved Serum Half-Life and Efficacy in a Rat Crohn’s Disease Model

PLoS ONE - United States
doi 10.1371/journal.pone.0050630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Serum Anti-Glycan Antibodies in Paediatric-Onset Crohn’s Disease: Association With Disease Phenotype and Diagnostic Accuracy

Przeglad Gastroenterologiczny
Gastroenterology
2014English

Effect of Herb-Partitioned Moxibustion on Autophagy and Immune-Associated Gene Expression Profiles in a Rat Model of Crohn’s Disease

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2019English

Spontaneous Gas Gangrene in a Patient With Crohn’s Disease

American Journal of Case Reports
Medicine
2012English

Crohn’s Disease With Oral Onset - A Case Report

Journal of Research in Dental and Maxillofacial Sciences
2016English

Virtual Colonoscopy-Induced Perforation in a Patient With Crohn’s Disease

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel With Exposome Markers in Crohn’s Disease

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

Single Daily Dosing of Antibiotics: Importance of in Vitro Killing Rate, Serum Half-Life, and Protein Binding.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1991English

Improved Efficacy of a Next-Generation ERT in Murine Pompe Disease

JCI insight
Medicine
2019English

Safety of P28GST, a Protein Derived From a Schistosome Helminth Parasite, in Patients With Crohn’s Disease: A Pilot Study (ACROHNEM)

Journal of Clinical Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy